# Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study

> **NCT07459595** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Fatima Tariq** · enrollment: 60 (estimated)

## Conditions studied

- Polycystic Ovarian Syndrome (PCOS)

## Interventions

- **DRUG:** Myoinositol
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT07459595
- **Lead sponsor:** Fatima Tariq
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459595, "Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07459595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*